- Home
- Industry Reports
- Healthcare
- Pharmaceuticals
- Global Alpha Emitters Market – Size, Outlook, Trends, and Forecast (2023 – 2030)
The global market for alpha emitters has been estimated at $XX million for the year 2018 and is projected to reach $XX million by 2024 at a CAGR of XX% during the forecast period 2018 to 2024. Alpha emitters are a type of radioactive substances that decay after emitting alpha particles. Alpha emitter radionuclide has been considered to be a new approach to treat many cancer types. Alpha-particles offer specific tumour cell killing actions causing less damage to surrounding healthy tissues than beta-emitters, and this potential has caught market attention.
Global Alpha Emitters Market Share:
Alpha emitter therapy holds a great promise when compared to chemotherapy as targeted alpha therapy allows easy discrimination between the healthy cells and cancer cells. The end-users of this market are usually Hospital, Imaging centres and research laboratories.
Global Alpha Emitters Market Size:
The number of therapeutic procedures recorded in North America, Europe and Asia-Pacific is 298, 22206, and 271262 respectively for the year 2018. Country-wise, US has 262 therapeutic procedures. Developing countries like India hold strong market potential, accounting for 7488 therapeutic procedures.
Global Alpha Emitters Market Growth:
The drivers contributing to the growth of the market are increasing incidences of cardiac & cancer ailments, raised awareness about the potential benefits of targeted alpha therapy and increasing availability of radiopharmaceuticals.
Global Alpha Emitters Market Industry Analysis:
Alpha Emitters market can be segmented by Radionuclide Types which include Terbium (Tb-149), Astatine (At-211), Bismuth (Bi-212), Bismuth (Bi-213), Actinium (Ac-225), Radium (Ra-223), Lead (Pb-212) and others. Based on Medical Application, the market is segmented into Endocrine Tumors, Lymphoma, Bone Metastasis, Thyroid, Ovarian Cancer, Pancreatic Cancer, Melanoma, etc.
Global Alpha Emitters Market Outlook:
Shorter life of radiopharmaceuticals need for high capital investment, stringent regulatory framework and reimbursement issues are the primary factors impacting the Alpha Emitters market growth.
Global Alpha Emitters Market Trends:
Nordion, Bruce Power and Cameco work together to provide a reliable supply of Cobalt-60. New Research by Cardinal Health Specialty Solutions Explores Oncologists’ Views on Emerging Therapies.
Global Alpha Emitters Market Research report includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as
- Nordion, Inc.
- Cardinal Health, Inc.
- AlphaTau
- Lantheus Medical Imaging
- Plexus NSD
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threat
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation, By Type of Radionuclide
6.1 Bismuth (Bi -213)
6.2 Lead (Pb-212)
6.3 Radium (Ra-223)
6.4 Actinium (Ac-225)
6.5 Bismuth (Bi-212)
6.6 Astatine (At-211)
6.7 Terbium (Tb-149)
6.8 Others
Chapter 7 Market Segmentation, By Medical Application
7.1 Endocrine Tumors
7.2 Lymphoma
7.3 Bone Metastasis
7.4 Thyroid
7.5 Ovarian Cancer
7.6 Pancreatic Cancer
7.7 Melanoma
7.8 Glioma
7.9 Others
Chapter 8 Market Segmentation, By Geography
8.1 North America
8.1.1 Introduction
8.1.2 United States
8.1.3 Canada
8.1.4 Mexico
8.1.5 Others
8.2 Europe
8.2.1 Introduction
8.2.2 U.K
8.2.3 Spain
8.2.4 Italy
8.2.5 France
8.2.6 Russia
8.2.7 Others
8.3 Asia-Pacific
8.3.1 Introduction
8.3.2 China
8.3.3 India
8.3.4 Japan
8.3.5 Australia
8.3.6 Others
8.4 South America
8.4.1 Introduction
8.4.2 Brazil
8.4.3 Argentina
8.4.4 Others
8.5 The Middle East & Africa
8.5.1 Introduction
8.5.2 South Africa
8.5.3 Others
Chapter 9 Competitive Landscape
9.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
9.2 Market Share Analysis
9.3 Strategies Adopted By Top Companies
Chapter 10 Company Profiles
10.1. Bayer Healthcare
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Strategic Initiative
10.2. Actinium Pharmaceuticals
10.3. NTP Radioisotopes
10.4. Siemens Healthcare
10.5. Triad Isotopes
10.6. Lantheus Medical Imaging
10.7. IBA Group
10.8. AlphaTau
10.9. Plexus NSD
10.10. Mallinckrodt PLC
10.11. Cardinal Health, Inc.
10.12. GE Healthcare
10.13. Bracco Imaging S.P.A
10.14. Eczacibasi-Monrol Nuclear Products
10.15. Nordion, Inc.
Chapter 11 Market Estimates and Forecast
11.1 Market Estimates and Forecast 2018-2024(USD Million)
11.1.1 Market Estimation and Forecast by Type of Radionuclide 2018-2024 (USD Million)
11.1.2 Market Estimation and Forecast by Medical Application 2018-2024 (USD Million)
11.1.3 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
Chapter 12 Market Insights
12.1 Insights of Industry Experts
12.2 Analyst Opinion (Market Understanding)
12.3 Investment Opportunities
Chapter 13 Appendix
13.1 List of Tables
13.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Global Report
$2,700.00 – $8,100.00
- EUR: €2,496.30 - €7,488.91
- INR: ₹225,001.66 - ₹675,004.99
- AED: د.إ9,909.00 - د.إ29,727.00
- GBP: £2,141.03 - £6,423.08
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
The global market for alpha emitters has been estimated at $XX million for the year 2018 and is projected to reach $XX million by 2024 at a CAGR of XX% during the forecast period 2018 to 2024. Alpha emitters are a type of radioactive substances that decay after emitting alpha particles. Alpha emitter radionuclide has been considered to be a new approach to treat many cancer types. Alpha-particles offer specific tumour cell killing actions causing less damage to surrounding healthy tissues than beta-emitters, and this potential has caught market attention.
Global Alpha Emitters Market Share:
Alpha emitter therapy holds a great promise when compared to chemotherapy as targeted alpha therapy allows easy discrimination between the healthy cells and cancer cells. The end-users of this market are usually Hospital, Imaging centres and research laboratories.
Global Alpha Emitters Market Size:
The number of therapeutic procedures recorded in North America, Europe and Asia-Pacific is 298, 22206, and 271262 respectively for the year 2018. Country-wise, US has 262 therapeutic procedures. Developing countries like India hold strong market potential, accounting for 7488 therapeutic procedures.
Global Alpha Emitters Market Growth:
The drivers contributing to the growth of the market are increasing incidences of cardiac & cancer ailments, raised awareness about the potential benefits of targeted alpha therapy and increasing availability of radiopharmaceuticals.
Global Alpha Emitters Market Industry Analysis:
Alpha Emitters market can be segmented by Radionuclide Types which include Terbium (Tb-149), Astatine (At-211), Bismuth (Bi-212), Bismuth (Bi-213), Actinium (Ac-225), Radium (Ra-223), Lead (Pb-212) and others. Based on Medical Application, the market is segmented into Endocrine Tumors, Lymphoma, Bone Metastasis, Thyroid, Ovarian Cancer, Pancreatic Cancer, Melanoma, etc.
Global Alpha Emitters Market Outlook:
Shorter life of radiopharmaceuticals need for high capital investment, stringent regulatory framework and reimbursement issues are the primary factors impacting the Alpha Emitters market growth.
Global Alpha Emitters Market Trends:
Nordion, Bruce Power and Cameco work together to provide a reliable supply of Cobalt-60. New Research by Cardinal Health Specialty Solutions Explores Oncologists’ Views on Emerging Therapies.
Global Alpha Emitters Market Research report includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as
- Nordion, Inc.
- Cardinal Health, Inc.
- AlphaTau
- Lantheus Medical Imaging
- Plexus NSD
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threat
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation, By Type of Radionuclide
6.1 Bismuth (Bi -213)
6.2 Lead (Pb-212)
6.3 Radium (Ra-223)
6.4 Actinium (Ac-225)
6.5 Bismuth (Bi-212)
6.6 Astatine (At-211)
6.7 Terbium (Tb-149)
6.8 Others
Chapter 7 Market Segmentation, By Medical Application
7.1 Endocrine Tumors
7.2 Lymphoma
7.3 Bone Metastasis
7.4 Thyroid
7.5 Ovarian Cancer
7.6 Pancreatic Cancer
7.7 Melanoma
7.8 Glioma
7.9 Others
Chapter 8 Market Segmentation, By Geography
8.1 North America
8.1.1 Introduction
8.1.2 United States
8.1.3 Canada
8.1.4 Mexico
8.1.5 Others
8.2 Europe
8.2.1 Introduction
8.2.2 U.K
8.2.3 Spain
8.2.4 Italy
8.2.5 France
8.2.6 Russia
8.2.7 Others
8.3 Asia-Pacific
8.3.1 Introduction
8.3.2 China
8.3.3 India
8.3.4 Japan
8.3.5 Australia
8.3.6 Others
8.4 South America
8.4.1 Introduction
8.4.2 Brazil
8.4.3 Argentina
8.4.4 Others
8.5 The Middle East & Africa
8.5.1 Introduction
8.5.2 South Africa
8.5.3 Others
Chapter 9 Competitive Landscape
9.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
9.2 Market Share Analysis
9.3 Strategies Adopted By Top Companies
Chapter 10 Company Profiles
10.1. Bayer Healthcare
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Strategic Initiative
10.2. Actinium Pharmaceuticals
10.3. NTP Radioisotopes
10.4. Siemens Healthcare
10.5. Triad Isotopes
10.6. Lantheus Medical Imaging
10.7. IBA Group
10.8. AlphaTau
10.9. Plexus NSD
10.10. Mallinckrodt PLC
10.11. Cardinal Health, Inc.
10.12. GE Healthcare
10.13. Bracco Imaging S.P.A
10.14. Eczacibasi-Monrol Nuclear Products
10.15. Nordion, Inc.
Chapter 11 Market Estimates and Forecast
11.1 Market Estimates and Forecast 2018-2024(USD Million)
11.1.1 Market Estimation and Forecast by Type of Radionuclide 2018-2024 (USD Million)
11.1.2 Market Estimation and Forecast by Medical Application 2018-2024 (USD Million)
11.1.3 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
Chapter 12 Market Insights
12.1 Insights of Industry Experts
12.2 Analyst Opinion (Market Understanding)
12.3 Investment Opportunities
Chapter 13 Appendix
13.1 List of Tables
13.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.